Trademark: 87105252
Word
BELLATRIX
Status Date
Monday, September 10, 2018
Filing Date
Friday, July 15, 2016
Published for Opposition
Tuesday, June 13, 2017
Abandoned Date
Monday, September 10, 2018
5 Pharmaceutical preparations for use in oncology, gastrointestinal and digestive disorders, endoscopy, dermatology, and the treatment of cancer, gastroenteric apparatus diseases, inflammatory diseases, diabetes, autoimmune diseases, Alzheimer's disease, allergies; nutraceuticals for use in oncology, gastrointestinal and digestive disorders, endoscopy, dermatology, and the treatment of cancer, gastroenteric apparatus diseases, inflammatory diseases, diabetes, autoimmune diseases, Alzheimer's disease, allergies; pharmaceutical preparations having bactericidal action for the treatment of cancer, gastroenteric apparatus diseases, inflammatory diseases, diabetes, autoimmune diseases, Alzheimer's disease, allergies; vaccines; sanitary preparations for medical purposes; dietary and nutritional supplements; diagnostic preparations for medical purposes; diagnostic reagents for medical use
The color(s) blue and orange is/are claimed as a feature of the mark.
The mark consists of the word "BELLATRIX" in blue font contained in an oval where the top arc is in shades of blue and the lower arc is in shades of orange.
Sep 10, 2018
Abandonment Notice Mailed - No Use Statement Filed
Sep 10, 2018
Abandonment - No Use Statement Filed
Feb 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2018
Corrected Noa E-Mailed
Feb 14, 2018
Divisional Processing Complete
Feb 8, 2018
Divisional Request Received
Feb 8, 2018
Teas Request To Divide Received
Feb 8, 2018
Extension 1 Granted
Feb 8, 2018
Extension 1 Filed
Feb 14, 2018
Case Assigned To Intent To Use Paralegal
Feb 8, 2018
Teas Extension Received
Aug 8, 2017
Noa E-Mailed - Sou Required From Applicant
Jun 13, 2017
Official Gazette Publication Confirmation E-Mailed
Jun 13, 2017
Published For Opposition
May 24, 2017
Notification Of Notice Of Publication E-Mailed
May 5, 2017
Law Office Publication Review Completed
Apr 24, 2017
Approved For Pub - Principal Register
Apr 18, 2017
Examiner's Amendment Entered
Apr 17, 2017
Notification Of Examiners Amendment E-Mailed
Apr 17, 2017
Examiners Amendment E-Mailed
Apr 17, 2017
Examiners Amendment -Written
Mar 1, 2017
Teas/Email Correspondence Entered
Mar 1, 2017
Correspondence Received In Law Office
Feb 21, 2017
Teas Response To Office Action Received
Nov 7, 2016
Notification Of Non-Final Action E-Mailed
Nov 7, 2016
Non-Final Action E-Mailed
Nov 7, 2016
Non-Final Action Written
Oct 26, 2016
Assigned To Examiner
Aug 15, 2016
Applicant Amendment Prior To Examination - Entered
Aug 12, 2016
Assigned To Lie
Aug 4, 2016
Assigned To Lie
Jul 27, 2016
Teas Voluntary Amendment Received
Jul 21, 2016
Notice Of Design Search Code E-Mailed
Jul 20, 2016
New Application Office Supplied Data Entered In Tram
Jul 19, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
